NEW YORK, Oct. 3 (GenomeWeb News) - Agendia has licensed Rosetta's Resolver software and the two companies will collaborate to offer diagnostics tools for gene-expression analysis, the firms said today.
Rosetta and Agendia will "enable interoperability between the Resolver system and Agendia's clinical and gene expression database" to support Agendia's research and development of diagnostic products and services, Yelena Shevelenko, vice president and general manager of Rosetta, said in a statement.
Financial terms of the deal were not disclosed.